Group One Trading
LGND icon

Group One Trading’s Ligand Pharmaceuticals LGND Stock Holding History

Group One Trading’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
3,514
+1,845
+111% +$435K ﹤0.01% 2766
2026
Q1 		$333K Sell
1,669
-1,284
-43% -$254K ﹤0.01% 3711
2025
Q4 		$558K Buy
2,953
+2,613
+769% +$502K ﹤0.01% 3395
2025
Q3 		$60.2K Buy
340
+100
+42% +$14.9K ﹤0.01% 5792
2025
Q2 		$27.3K Buy
+240
New +$25.7K ﹤0.01% 6066
2024
Q1 		– Sell
-916
Closed -$67.5K – 7539
2023
Q4 		$65.4K Sell
916
-8,005
-90% -$472K ﹤0.01% 4838
2023
Q3 		$535K Buy
+8,921
New +$587K ﹤0.01% 2841
2018
Q4 		– Sell
-4,051
Closed -$432K – 5162
2018
Q3 		$694K Buy
4,051
+3,754
+1,264% +$566K 0.01% 1987
2018
Q2 		$38K Sell
297
-1,152
-80% -$129K ﹤0.01% 4095
2018
Q1 		$149K Sell
1,449
-797
-35% -$78.8K ﹤0.01% 2989
2017
Q4 		$192K Sell
2,246
-3,272
-59% -$284K ﹤0.01% 2950
2017
Q3 		$469K Buy
+5,518
New +$437K ﹤0.01% 2122
2017
Q2 		– Sell
-60,480
Closed -$4.23M – 4913
2017
Q1 		$3.99M Buy
60,480
+21,790
+56% +$1.43M 0.05% 499
2016
Q4 		$2.45M Buy
38,690
+37,613
+3,492% +$2.37M 0.02% 799
2016
Q3 		$69K Buy
+1,077
New +$79.1K ﹤0.01% 3149
2016
Q2 		– Sell
-2,456
Closed -$182K – 4787
2016
Q1 		$164K Sell
2,456
-2,866
-54% -$174K ﹤0.01% 2458
2015
Q4 		$360K Buy
5,322
+1,827
+52% +$113K ﹤0.01% 2069
2015
Q3 		$187K Sell
3,495
-3,818
-52% -$232K ﹤0.01% 2547
2015
Q2 		$460K Buy
7,313
+2,001
+38% +$109K 0.01% 1853
2015
Q1 		$256K Buy
+5,312
New +$204K ﹤0.01% 2180
2014
Q4 		– Sell
-385
Closed -$12.5K – 5096
2014
Q3 		$11K Buy
+385
New +$12.8K ﹤0.01% 4419
2013
Q4 		– Sell
-4,351
Closed -$142K – 5384
2013
Q3 		$117K Buy
+4,351
New +$122K ﹤0.01% 2878

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's LGND Position: Q2 2026 in Review

Group One Trading increased its Ligand Pharmaceuticals (LGND) stake by 111% in Q2 2026, buying an estimated $435K and bringing the position to 3,514 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2766.

Group One Trading first reported a position in LGND in Q3 2013 and has held it in 22 quarters since. The position peaked at $3.99M in Q1 2017. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Group One Trading held 3,514 shares of Ligand Pharmaceuticals worth $1.11M as of Q2 2026.
  • Group One Trading bought 1,845 Ligand Pharmaceuticals shares in Q2 2026, an estimated $435K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #2766 holding.
  • Group One Trading first reported a position in Ligand Pharmaceuticals in Q3 2013 and has held it in 22 quarters since.
  • Group One Trading's Ligand Pharmaceuticals position peaked at $3.99M in Q1 2017.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.